H5N1 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
Conditions:   Influenza A Virus Infection;   Influenza A;   Influenza Epidemic;   Influenza H5N1 Intervention:   Biological: GamFluVac Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2018 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered With or Without Topical Aldara
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Other: Aqueous Cream B.P.;   Drug: Imiquimod;   Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials